(30 days)
Not Found
No
The description focuses on customized implants based on CT data and surgeon input, with no mention of AI or ML algorithms for design, analysis, or other functions.
Yes
The device is intended to replace bony voids in the cranial and craniofacial skeleton, which is a structural repair to the body and therefore therapeutic.
No
This device is a cranial implant designed to replace bony voids, not diagnose conditions. It is a treatment device, not a diagnostic one.
No
The device description explicitly states it is a "Stryker PEEK Customized Cranial Implant Kit" and "PEEK Customized Cranial Implant," which are physical implants made of PEEK material. While the design process uses CT data and surgeon input (which likely involves software), the final product is a physical implant, not software itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Stryker PEEK Customized Cranial Implant Kit is a physical implant intended to replace bony voids in the skull. It is a surgical device, not a diagnostic test performed on a sample.
- Intended Use: The intended use is to "replace bony voids" and "filling bony voids," which describes a therapeutic or reconstructive purpose, not a diagnostic one.
- Device Description: The description clearly states it is a "customized cranial or craniofacial patient specific implant."
Therefore, this device falls under the category of a surgical implant or medical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Stryker PEEK Customized Cranial Implant Kit is intended to replace bony voids in the cranial and the craniofacial skeleton.
The Stryker PEEK Customized Cranial Implant Kit is indicated for filling bony voids in the craniofacial skeleton in patients 12 years of age and older.
Product codes
GWO
Device Description
The Stryker PEEK Customized Cranial Implant (CCI) is intended to replace bony voids in the cranial and the craniofacial skeleton in patients 12 years of age and older. The PEEK CCI product offerings provide customized cranial or craniofacial patient specific implants based on CT data and surgeon input. This special 510(k) is being submitted due to the optional removal of the Host Bone Model from the PEEK CCI Kit which creates the PEEK Customized Cranial Priority Implant product offering, and also the standard PEEK Customized Cranial Implant product offering.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT data
Anatomical Site
cranial and craniofacial skeleton
Indicated Patient Age Range
patients 12 years of age and older.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Performance bench testing was not required as a basis for substantial equivalence as evaluated by the performed risk analysis.
Animal testing was not required as a basis for substantial equivalence.
Clinical testing was not required as a basis for substantial equivalence.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.5320 Preformed alterable cranioplasty plate.
(a)
Identification. A preformed alterable cranioplasty plate is a device that is implanted into a patient to repair a skull defect. It is constructed of a material, e.g., tantalum, that can be altered or reshaped at the time of surgery without changing the chemical behavior of the material.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of three human profiles facing to the right, with flowing lines suggesting hair or movement. The profiles are stacked on top of each other, creating a sense of unity and progress. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the central image.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 26, 2015
Stryker Craniomaxillofacial Mr. Jonathan Schell Senior Regulatory Affairs Specialist 750 Trade Centre Way Suite 200 Portage. Michigan 49002
Re: K152076
Trade/Device Name: Stryker PEEK Customized Cranial Implant Kit Regulation Number: 21 CFR 882.5320 Regulation Name: Preformed Alterable Cranioplasty Plate Regulatory Class: Class II Product Code: GWO Dated: July 24, 2015 Received: July 27, 2015
Dear Mr. Jonathan Schell:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Carlos L. Pena -S
Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K152076
Device Name Stryker PEEK Customized Cranial Implant Kit
Indications for Use (Describe)
The Stryker PEEK Customized Cranial Implant Kit is intended to replace bony voids in the cranial and the craniofacial skeleton.
The Stryker PEEK Customized Cranial Implant Kit is indicated for filling bony voids in the craniofacial skeleton in patients 12 years of age and older.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the word "stryker" in a bold, sans-serif font. The word is all lowercase except for the first letter, which is uppercase. There is a registered trademark symbol to the upper right of the word. The word is in black and the background is white.
510(k) Summary
This section provides a summary of 510(k) information in accordance with the requirements of 21 CFR 807.92.
I. SUBMITTER
| 510(k) Owner: | Stryker Leibinger GmbH& Co. KG
Boetzinger Strasse 41
D-79111 Freiburg, Germany |
|-------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter/ Contact
Person: | Jonathan Schell
Sr. Regulatory Affairs Specialist
Stryker Craniomaxillofacial
750 Trade Centre Way
Portage, MI 49002
Phone: 269-389-5596
Fax: 877-648-7114 |
| Date prepared: | July 24, 2015 |
| II. DEVICE | |
| Trade Name: | Stryker PEEK Customized Cranial Implant Kit |
| Common or Usual
name: | Customized Cranial Implant |
| Classification
name: | Preformed alterable cranioplasty plate 21 CFR §882.5320 |
| Regulatory Class: | Class II |
| Product Code: | GWO |
4
Image /page/4/Picture/0 description: The image shows the word "stryker" in a bold, sans-serif font. The word is all lowercase, and there is a small, superscripted "®" symbol to the right of the "r". The logo is black and the background is white.
PREDICATE DEVICE III.
Predicate: Stryker PEEK Customized Cranial Implant Kit - K121153
This predicate has not been subject to a design-related recall.
IV. DEVICE DESCRIPTION
The Stryker PEEK Customized Cranial Implant (CCI) is intended to replace bony voids in the cranial and the craniofacial skeleton in patients 12 years of age and older. The PEEK CCI product offerings provide customized cranial or craniofacial patient specific implants based on CT data and surgeon input. This special 510(k) is being submitted due to the optional removal of the Host Bone Model from the PEEK CCI Kit which creates the PEEK Customized Cranial Priority Implant product offering, and also the standard PEEK Customized Cranial Implant product offering.
INDICATIONS FOR USE
The Stryker PEEK Customized Cranial Implant Kit is intended to be used to replace bony voids in the cranial and the craniofacial skeleton.
The Stryker PEEK Customized Cranial Implant Kit is indicated for filling bony voids in the cranial and craniofacial skeleton in patients 12 years of age and older.
The proposed modifications do not alter the Indications for Use statement for the proposed device. The Indications for Use is identical to the predicate device Stryker PEEK Customized Cranial Implant Kit (K121153).
COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE V. PREDICATE DEVICE
The modified PEEK CCI Kit is compared to its predicate device for substantial equivalence of technological characteristics based on the following criteria:
- A. Principle of Operation
- B. Technological Characteristics
5
A. Principle of Operation
The basic operational principle of the modified PEEK CCI Kit remains the same as the predicate: the operating principle for the PEEK CCI is to fill bony voids in the cranial and craniofacial skeleton. The method of site preparation and fixation remains unchanged.
B. Technological Characteristics
Making the Host Bone Model optional, and the addition of two new product offerings to the PEEK CCI Kit does not alter the technological characteristics of the actual customized cranial or craniofacial implant. The technological characteristics remain the same:
- -Same operating principle: to fill bony voids in the craniofacial skeleton.
- Same mode of fixation: fixated to the native bone with Stryker Neuro, Midface, and, or, Upperface self-tapping screws. The Stryker Neuro, Midface, and, or, Upperface standard drill bits are used to drill the pilot hole.
- Same material: Implants are made of medical grade PEEK Optima LT1. Both predicate and subject devices are milled out of a block using industrial milling machines.
- -Same design: Provides a "drop-in-fit" without a need for intra-operative modifications. If minor intra-operative size reduction is required, the implant can be trimmed with standard surgical burrs by the surgeon.
PERFORMANCE DATA VI.
The modification described in this submission is the optional removal of the Host Bone Model from the PEEK CCI Kit, which creates additional product offerings. There are no proposed changes to the device itself. A risk analysis was performed and the results confirmed that no new performance tests were needed for the modified product offerings.
Biocompatibility and sterility testing of the new product offerings was not required as a basis for substantial equivalence. There is no change in the material, duration or location of contact, or reprocessing methods.
Performance Bench Testing
Performance bench testing was not required as a basis for substantial equivalence as evaluated by the performed risk analysis.
Animal Testing
Animal testing was not required as a basis for substantial equivalence.
6
Clinical Testing
Clinical testing was not required as a basis for substantial equivalence.
VII. CONCLUSIONS
According to the comparison based on the requirements of 21 CFR 807.87 and the information provided herein, it is concluded that the information included in this submission supports substantial equivalence.